225526-17-0
中文名稱(chēng)
225526-17-0
英文名稱(chēng)
3-Piperidinamine, N-[[3,4-dihydro-6-methoxy-1-methyl-1-(trifluoromethyl)-1H-2-benzopyran-7-yl]methyl]-2-phenyl-, (2S,3S)-
CAS
225526-17-0
分子式
C24H29F3N2O2
分子量
434.494
MOL 文件
225526-17-0.mol
225526-17-0 結(jié)構(gòu)式
基本信息
中文別名
SUBSTANCE P RECEPTOR ANTAGONIST 1 英文別名
Substance P Receptor Antagonist 13-Piperidinamine, N-[[3,4-dihydro-6-methoxy-1-methyl-1-(trifluoromethyl)-1H-2-benzopyran-7-yl]methyl]-2-phenyl-, (2S,3S)-
物理化學(xué)性質(zhì)
沸點(diǎn)511.0±50.0 °C(Predicted)
密度1.23±0.1 g/cm3(Predicted)
儲(chǔ)存條件-20°C儲(chǔ)存
溶解度溶于二甲基亞砜
酸度系數(shù)(pKa)9.15±0.10(Predicted)
常見(jiàn)問(wèn)題列表
生物活性
Substance P Receptor Antagonist 1 在中樞神經(jīng)系統(tǒng)疾病，呼吸疾病和炎癥以及腸胃失調(diào)等方面具有潛在的作用。體外研究
Substance P Receptor Antagonist 1 has the potential function in numerous diseases, including central nervous system disorders such as depression, anxiety and schizophrenia, in respiratory and inflammatory diseases such as asthma and rheumatoid arthritis, in gastrointestinal disorders and diseases of the GI tract such as ulcerative colitis and Crohn's disease, and in the transmission of pain, including migraine.